Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyBelén Gutiérrez‐Gutiérrez, Mario Fernández‐Ruiz, Marco Falcone et al.|The Lancet Infectious Diseases|2017Cited by 521
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>Mario Tumbarello, Pierluigi Viale, Enrico Maria Trecarichi et al.|Clinical Infectious Diseases|2018Cited by 351
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter StudyMario Tumbarello, Pierluigi Viale, Francesca Raffaelli et al.|Clinical Infectious Diseases|2021Cited by 264
Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conferenceMassimo Sartelli, Ernest E. Moore, Fausto Catena et al.|World Journal of Emergency Surgery|2017Cited by 205
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patientsRaffaele Marfella, Giuseppe Paolisso, Pasquale Paolisso et al.|Diabetes & Metabolism|2020Cited by 138